These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28894311)
21. Pharmacists' experiences on adverse drug reaction: 10 years later. Karuppannan M; Mohamad Rizal NAN; Wong KT; Mohd Ali S; Ting KN; Boardman H Front Pharmacol; 2022; 13():932942. PubMed ID: 36249772 [TBL] [Abstract][Full Text] [Related]
22. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808 [TBL] [Abstract][Full Text] [Related]
24. Adverse drug reaction and medication error reporting by pharmacy students. Sears EL; Generali JA Ann Pharmacother; 2005 Mar; 39(3):452-9. PubMed ID: 15701765 [TBL] [Abstract][Full Text] [Related]
25. Impact of a Policy Change on Pharmacists' Reporting of Adverse Drug Reactions. Roy R; Ma J Can J Hosp Pharm; 2018; 71(4):227-233. PubMed ID: 30185996 [TBL] [Abstract][Full Text] [Related]
26. Impact of the development of a multidisciplinary adverse drug reaction committee. Etzel JV; Brocavich JM; Rousseau M Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655 [TBL] [Abstract][Full Text] [Related]
27. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China. Su C; Ji H; Su Y Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911 [TBL] [Abstract][Full Text] [Related]
28. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia. Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612 [No Abstract] [Full Text] [Related]
29. Monitoring drug safety in Astrakhan, Russia. Kirilochev OO; Dorfman IP; Umerova AR Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700 [TBL] [Abstract][Full Text] [Related]
30. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study. Ball D; Tisócki T Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417 [TBL] [Abstract][Full Text] [Related]
31. Medication safety knowledge, attitude, and practice among hospital pharmacists in Lebanon. Hallit S; Hajj A; Shuhaiber P; Iskandar K; Ramia E; Sacre H; Salameh P; J Eval Clin Pract; 2019 Apr; 25(2):323-339. PubMed ID: 30592116 [TBL] [Abstract][Full Text] [Related]
32. Adverse drug reactions reporting by undergraduate medical students in a tertiary care teaching hospital of India: Content and quality analysis in comparison to physician reporting. Patel PB; Patel TK; Anturlikar S; Khatun S; Bhabhor P; Saurabh MK Perspect Clin Res; 2017; 8(3):137-144. PubMed ID: 28828309 [TBL] [Abstract][Full Text] [Related]
33. Use of standardized screening procedures to identify adverse drug reactions. Koch KE Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724 [TBL] [Abstract][Full Text] [Related]
34. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND. Zimmermann A; Gaworska-Krzeminska A; Flis A Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080 [TBL] [Abstract][Full Text] [Related]
35. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Herdeiro MT; Polónia J; Gestal-Otero JJ; Figueiras A Drug Saf; 2008; 31(4):335-44. PubMed ID: 18366244 [TBL] [Abstract][Full Text] [Related]
36. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs. Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223 [TBL] [Abstract][Full Text] [Related]
37. Review of Canadian pharmacist involvement in adverse drug reaction reporting. Taras-Zasowski KM; Einarson TR Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271 [TBL] [Abstract][Full Text] [Related]
38. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study. Ting KN; Stratton-Powell DM; Anderson C Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371 [TBL] [Abstract][Full Text] [Related]
39. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518 [TBL] [Abstract][Full Text] [Related]
40. Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh. Amin MN; Khan TM; Dewan SM; Islam MS; Moghal MR; Ming LC BMJ Open; 2016 Aug; 6(8):e010912. PubMed ID: 27489151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]